NewAmsterdam Pharma Company N.V. Warrant (NAMSW) at a glance
NewAmsterdam Pharma Company N.V. Warrant (NAMSW) is a Healthcare company. It trades at $16.51, with a 0% profit margin and revenue decline of 80.7%. It does not pay a dividend. Vestovix scores it 46/100 overall. Its strongest dimension is Safety (99/100) and its weakest is Growth (11/100). It is a relatively defensive holding with below-market volatility.
- Price
- $16.51
- Market cap
- n/a
- P/E ratio
- n/a
- Dividend yield
- None
- Beta
- 0.11
- 52-week range
- $12.69 to $30.45
Value
50
Growth
11
Income
40
Safety
99
Momentum
28
Other Healthcare stocks
See allDHR.PR.A50
Danaher Corp
$1,841.01+0.00%
2.58% yield
LLY68
Eli Lilly and Company
$1,143.00-0.96%
0.57% yield
JNJ61
Johnson & Johnson
$268.68+0.73%
2.18% yield
ABBV46
AbbVie Inc.
$265.05-0.86%
2.96% yield
UNH56
UnitedHealth Group Incorporated
$377.10-0.34%
2.16% yield
MRK60
Merck & Co., Inc.
$150.37-0.98%
2.79% yield
ABT54
Abbott Laboratories
$103.12+0.92%
2.16% yield
AMGN65
Amgen Inc.
$392.00-1.05%
2.76% yield